
Neogenomics Inc
NASDAQ:NEO

Intrinsic Value
The intrinsic value of one
NEO
stock under the Base Case scenario is
13.88
USD.
Compared to the current market price of 7.44 USD,
Neogenomics Inc
is
Undervalued by 46%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Neogenomics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Neogenomics Inc
Balance Sheet Decomposition
Neogenomics Inc
Current Assets | 573.9m |
Cash & Short-Term Investments | 358.1m |
Receivables | 151.2m |
Other Current Assets | 64.6m |
Non-Current Assets | 1B |
PP&E | 167.4m |
Intangibles | 854.1m |
Other Non-Current Assets | 6m |
Free Cash Flow Analysis
Neogenomics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Neogenomics Inc
Revenue
|
672.4m
USD
|
Cost of Revenue
|
-374.5m
USD
|
Gross Profit
|
297.9m
USD
|
Operating Expenses
|
-383m
USD
|
Operating Income
|
-85.1m
USD
|
Other Expenses
|
7.5m
USD
|
Net Income
|
-77.6m
USD
|
NEO Profitability Score
Profitability Due Diligence
Neogenomics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Score
Neogenomics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
NEO Solvency Score
Solvency Due Diligence
Neogenomics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Score
Neogenomics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NEO Price Targets Summary
Neogenomics Inc
According to Wall Street analysts, the average 1-year price target for
NEO
is 11.09 USD
with a low forecast of 8.08 USD and a high forecast of 15.75 USD.
Dividends
Current shareholder yield for NEO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NEO
stock under the Base Case scenario is
13.88
USD.
Compared to the current market price of 7.44 USD,
Neogenomics Inc
is
Undervalued by 46%.